HeartBeam has submitted a 510 (k) application to the US Food and Drug Administration (FDA) for its 12-lead electrocardiogram ...

HeartBeam (NASDAQ: BEAT) , a medical technology company advancing cardiac care, has submitted a 510 (k) application to the U.S. Food and Drug Administration (“FDA”) for its 12-lead electrocardiogram ( ...

The atrial fibrillation (AF) device market is experiencing rapid growth, fueled by the rising prevalence of atrial fibrillation, increasing awareness of early diagnosis, and advancements in medical ...

The FDA submission is backed by robust data from the VALID-ECG pivotal study, which enrolled 198 patients across five ...

As per a survey, only a fraction of smartwatch users share details of their health stats with a doctor, a misstep that could ...

At McLeod Regional Medical Center, McLeod Electrophysiologists Dr. Prabal Guha and Dr. Cyrus Kocherla are performing safe and successful ablations in patients using the new FDA-approved pulsed field ...

Cardiovascular diseases are the leading cause of death globally and in Brazil. The provision of quality healthcare faces ...

Tim Cook recounted how an alert from his father’s Apple Watch summoned emergency services after his father fell at home and ...

Excessive supraventricular ectopic activity (ESVEA) in the acute phase of ischemic stroke or transient ischemic attack (TIA) ...

Those in the EU and Australia will soon be able to use the ECG heart health feature in the Fenix 8, Enduro 3 and Venu 3 watches.

The company announced that the ECG app is now available in the EU and Australia. As you might expect, the ECG app lets you ...